{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T03:42:15Z","timestamp":1782445335025,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2415-13-74","type":"journal-article","created":{"date-parts":[[2013,12,5]],"date-time":"2013-12-05T01:26:58Z","timestamp":1386206818000},"source":"Crossref","is-referenced-by-count":24,"title":["Health state utilities in patients with diabetic retinopathy, diabetic macular oedema and age-related macular degeneration: a systematic review"],"prefix":"10.1186","volume":"13","author":[{"given":"Edith","family":"Poku","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Brazier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Carlton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,4]]},"reference":[{"key":"369_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0167-6296(86)90020-2","volume":"5","author":"GW Torrance","year":"1986","unstructured":"Torrance GW: Measurement of health state utilities for economic appraisal. J Health Econ. 1986, 5: 1-30.","journal-title":"J Health Econ"},{"key":"369_CR2","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198529446.001.0001","volume-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"MF Drummond","year":"2005","unstructured":"Drummond MF, Sculpher MJ, O\u2019Brien BJ, Stoddart GL: Methods for the Economic Evaluation of Health Care Programmes. 2005, Oxford: Oxford University Press, 3","edition":"3"},{"key":"369_CR3","volume-title":"Measuring and Valuing Health Benefits for Economic Evaluations","author":"J Brazier","year":"2007","unstructured":"Brazier J, Ratcliffe J, Tsuchiya A: Measuring and Valuing Health Benefits for Economic Evaluations. 2007, Oxford: Oxford University Press"},{"key":"369_CR4","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","volume":"35","author":"P Dolan","year":"1997","unstructured":"Dolan P: Modeling valuations for EuroQol health states. Med Care. 1997, 35: 1095-1108.","journal-title":"Med Care"},{"key":"369_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0167-6296(01)00130-8","volume":"21","author":"J Brazier","year":"2002","unstructured":"Brazier J, Roberts J, Deverill M: The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002, 21: 271-292.","journal-title":"J Health Econ"},{"key":"369_CR6","doi-asserted-by":"publisher","first-page":"490","DOI":"10.2165\/00019053-199507060-00004","volume":"7","author":"D Feeny","year":"1995","unstructured":"Feeny D, Furlong W, Boyle M, Torrance GW: Multi-attribute health status classification systems. Health utilities index. Pharmacoeconomics. 1995, 7: 490-502.","journal-title":"Pharmacoeconomics"},{"key":"369_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta16320","volume":"16","author":"JE Brazier","year":"2012","unstructured":"Brazier JE, Rowen D, Mavranezouli I, Tsuchiya A, Young T, Yang Y, et al: Developing and testing methods for deriving preference-based measures of health from condition-specific measures (and other patient-based measures of outcome). Health Technol Assess. 2012, 16: 1-114.","journal-title":"Health Technol Assess"},{"key":"369_CR8","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1177\/0272989X10379646","volume":"31","author":"Y Yang","year":"2011","unstructured":"Yang Y, Brazier JE, Tsuchiya A, Young TA: Estimating a preference-based index for a 5-dimensional health state classification for asthma derived from the asthma quality of life questionnaire. Med Decis Making. 2011, 31: 281-291.","journal-title":"Med Decis Making"},{"key":"369_CR9","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.jval.2012.08.2201","volume":"15","author":"D Rowen","year":"2012","unstructured":"Rowen D, Young T, Brazier J, Gaugris S: Comparison of generic, condition-specific, and mapped health state utility values for multiple myeloma cancer. Value Health. 2012, 15: 1059-1068.","journal-title":"Value Health"},{"key":"369_CR10","doi-asserted-by":"publisher","first-page":"v-140","DOI":"10.3310\/hta17050","volume":"17","author":"B Mulhern","year":"2013","unstructured":"Mulhern B, Rowen D, Brazier J, Smith S, Romeo R, Tait R, et al: Development of DEMQOL-U and DEMQOL-PROXY-U: generation of preference-based indices from DEMQOL and DEMQOL-PROXY for use in economic evaluation. Health Technol Assess. 2013, 17: v-140-","journal-title":"Health Technol Assess"},{"key":"369_CR11","volume-title":"Guide to Methods of Technology Appraisals","author":"National Institute for Health and Care Excellence","year":"2013","unstructured":"National Institute for Health and Care Excellence: Guide to Methods of Technology Appraisals. 2013, London, http:\/\/www.nice.org.uk\/media\/D45\/1E\/GuideToMethodsTechnologyAppraisal2013.pdf Last accessed 21st August 2013"},{"key":"369_CR12","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2147\/OPTH.S6024","volume":"3","author":"K Evans","year":"2009","unstructured":"Evans K, Law SK, Walt J, Buchholz P, Hansen J: The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration. Clin Ophthalmol. 2009, 3: 433-445.","journal-title":"Clin Ophthalmol"},{"key":"369_CR13","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1167\/iovs.11-8992","volume":"53","author":"EK Fenwick","year":"2012","unstructured":"Fenwick EK, Xie J, Ratcliffe J, Pesudovs K, Finger RP, Wong TY, et al: The impact of diabetic retinopathy and diabetic macular edema on health-related quality of life in type 1 and type 2 diabetes. Invest Ophthalmol Vis Sci. 2012, 53: 677-684.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"369_CR14","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jval.2011.08.002","volume":"15","author":"J Tosh","year":"2012","unstructured":"Tosh J, Brazier J, Evans P, Longworth L: A review of generic preference-based measures of health-related quality of life in visual disorders. Value Health. 2012, 15: 118-127.","journal-title":"Value Health"},{"key":"369_CR15","unstructured":"Papaioannou D, Brazier J, Paisley S: NICE DSU Technical Support Document 9: The identification, review and synthesis of health state utility values from the literature. http:\/\/www.nicedsu.org.uk\/TSD9%20HSUV%20values_FINAL.pdf . 2010 Last accessed 20th August 2013"},{"key":"369_CR16","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1001\/archopht.120.4.481","volume":"120","author":"MM Brown","year":"2002","unstructured":"Brown MM, Brown GC, Sharma S, Landy J, Bakal J: Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration. Arch Ophthalmol. 2002, 120: 481-484.","journal-title":"Arch Ophthalmol"},{"key":"369_CR17","volume-title":"Visual acuity measurement standard","author":"International Council of Ophthalmology","year":"1998","unstructured":"International Council of Ophthalmology: Visual acuity measurement standard. 1998, http:\/\/www.icoph.org\/resources\/47\/Visual-Acuity-Measurement-Standard.html Last accessed 3rd May 2013"},{"key":"369_CR18","volume-title":"Calculating the exact pooled variance","author":"JW Rudmin","year":"2010","unstructured":"Rudmin JW: Calculating the exact pooled variance. 2010, http:\/\/arxiv.org\/ftp\/arxiv\/papers\/1007\/1007.1012.pdf ] Last accessed 3rd May 2013"},{"key":"369_CR19","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1136\/bjo.2006.104679","volume":"91","author":"PA Aspinall","year":"2007","unstructured":"Aspinall PA, Hill AR, Dhillon B, Armbrecht AM, Nelson P, Lumsden C, et al: Quality of life and relative importance: a comparison of time trade-off and conjoint analysis methods in patients with age-related macular degeneration. Br J Ophthalmol. 2007, 91: 766-772.","journal-title":"Br J Ophthalmol"},{"key":"369_CR20","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/eye.2011.218","volume":"26","author":"KG Au Eong","year":"2012","unstructured":"Au Eong KG, Chan EW, Luo N, Wong SH, Tan NW, Lim TH, et al: Validity of EuroQOL-5D, time trade-off, and standard gamble for age-related macular degeneration in the Singapore population. Eye (Lond). 2012, 26: 379-388.","journal-title":"Eye (Lond)"},{"key":"369_CR21","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/j.1524-4733.2009.00527.x","volume":"12","author":"CC Czoski-Murray","year":"2009","unstructured":"Czoski-Murray CC: Valuing condition-specific health states using simulation contact lenses. Value in Health. 2009, 12: 793-799.","journal-title":"Value in Health"},{"key":"369_CR22","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.1167\/iovs.05-0072","volume":"46","author":"M Espallargues","year":"2005","unstructured":"Espallargues M, Czoski-Murray CJ, Bansback NJ, Carlton J, Lewis GM, Hughes LA, et al: The impact of age-related macular degeneration on health status utility values. Invest Ophthalmol Vis Sci. 2005, 46: 4016-4023.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"369_CR23","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.ophtha.2007.06.008","volume":"115","author":"BS Lee","year":"2008","unstructured":"Lee BS, Kymes SM, Nease RFJ, Sumner W, Siegfried CJ, Gordon MO: The impact of anchor point on utilities for 5 common ophthalmic diseases. Ophthalmology. 2008, 115: 898-903.","journal-title":"Ophthalmology"},{"key":"369_CR24","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/j.1464-5491.2008.02430.x","volume":"25","author":"A Lloyd","year":"2008","unstructured":"Lloyd A, Nafees B, Gavriel S, Rousculp MD, Boye KS, Ahmad A: Health utility values associated with diabetic retinopathy. Diabet Med. 2008, 25: 618-624.","journal-title":"Diabet Med"},{"key":"369_CR25","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1016\/j.ophtha.2009.10.031","volume":"116","author":"BC Reeves","year":"2009","unstructured":"Reeves BC, Langham J, Walker J, Grieve R, Chakravarthy U, Tomlin K, et al: Verteporfin photodynamic therapy cohort study: report 2: Clinical measures of vision and health-related quality of life. Ophthalmology. 2009, 116: 2463-2470.","journal-title":"Ophthalmology"},{"key":"369_CR26","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1001\/archopht.125.7.945","volume":"125","author":"JA Sahel","year":"2007","unstructured":"Sahel JA, Bandello F, Augustin A, Maurel F, Negrini C, Berdeaux GH, et al: Health-related quality of life and utility in patients with age-related macular degeneration. Arch Ophthalmol. 2007, 125: 945-951.","journal-title":"Arch Ophthalmol"},{"key":"369_CR27","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1136\/bjo.87.3.259","volume":"87","author":"S Sharma","year":"2003","unstructured":"Sharma S, Oliver-Fernandez A, Bakal J, Hollands H, Brown GC, Brown MM: Utilities associated with diabetic retinopathy: results from a Canadian sample. Br J Ophthalmol. 2003, 87: 259-261.","journal-title":"Br J Ophthalmol"},{"key":"369_CR28","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1001\/archopht.125.9.1249","volume":"125","author":"G Soubrane","year":"2007","unstructured":"Soubrane G, Cruess A, Lotery A, Pauleikhoff D, Mones J, Xu X, et al: Burden and health care resource utilization in neovascular age-related macular degeneration: findings of a multicountry study. Arch Ophthalmol. 2007, 125: 1249-1254.","journal-title":"Arch Ophthalmol"},{"key":"369_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10384-010-0893-y","volume":"55","author":"Y Yanagi","year":"2011","unstructured":"Yanagi Y, Ueta T, Obata R, Iriyama A, Fukuda T, Hashimoto H, et al: Utility values in Japanese patients with exudative age-related macular degeneration. Jpn J Ophthalmol. 2011, 55: 35-38.","journal-title":"Jpn J Ophthalmol"},{"key":"369_CR30","first-page":"473","volume":"97","author":"GC Brown","year":"1999","unstructured":"Brown GC: Vision and quality-of-life. Trans Am Ophthalmol Soc. 1999, 97: 473-511.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"369_CR31","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0161-6420(00)00635-7","volume":"108","author":"MM Brown","year":"2001","unstructured":"Brown MM, Brown GC, Sharma S, Busbee B, Brown H: Quality of life associated with unilateral and bilateral good vision. Ophthalmology. 2001, 108: 643-647.","journal-title":"Ophthalmology"},{"key":"369_CR32","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/S0161-6420(03)00254-9","volume":"110","author":"MM Brown","year":"2003","unstructured":"Brown MM, Brown GC, Sharma S, Busbee B: Quality of life associated with visual loss: a time tradeoff utility analysis comparison with medical health states. Ophthalmology. 2003, 110: 1076-1081.","journal-title":"Ophthalmology"},{"key":"369_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1076\/opep.11.1.43.26436","volume":"11","author":"VA Shah","year":"2004","unstructured":"Shah VA, Gupta SK, Shah KV, Vinjamaram S, Chalam KV: TTO utility scores measure quality of life in patients with visual morbidity due to diabetic retinopathy or ARMD. Ophthalmic Epidemiol. 2004, 11: 43-51.","journal-title":"Ophthalmic Epidemiol"},{"key":"369_CR34","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1136\/bjo.86.5.493","volume":"86","author":"S Sharma","year":"2002","unstructured":"Sharma S, Brown GC, Brown MM, Hollands H, Robins R, Shah GK: Validity of the time trade-off and standard gamble methods of utility assessment in retinal patients. Br J Ophthalmol. 2002, 86: 493-496.","journal-title":"Br J Ophthalmol"},{"key":"369_CR35","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1023\/A:1021171000838","volume":"24","author":"MM Brown","year":"2001","unstructured":"Brown MM, Brown GC, Sharma S, Smith AF, Landy J: A utility analysis correlation with visual acuity: methodologies and vision in the better and poorer eyes. Int Ophthalmol. 2001, 24: 123-127.","journal-title":"Int Ophthalmol"},{"key":"369_CR36","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1177\/0272989X9701700303","volume":"17","author":"DG Fryback","year":"1997","unstructured":"Fryback DG, Lawrence WF: Dollars may not buy as many QALYs as we think: a problem with defining quality-of-life adjustments. Med Decis Making. 1997, 17: 276-284.","journal-title":"Med Decis Making"},{"key":"369_CR37","volume-title":"Health Technol Assess Monogr Ser","author":"L Longworth","year":"2013","unstructured":"Longworth L, Yang Y, Young T, Mulhern B, Hernandez Alva M, Mukuria C, et al: Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: systematic review, statistical modelling and survey. Health Technol Assess Monogr Ser. 2013, In press"},{"key":"369_CR38","unstructured":"Solem C, Pickard A: Identification of Diseases for EQ-5D Bolt-On Items\/Dimension Extensions Development: An Empirical Approach. http:\/\/download.journals.elsevierhealth.com\/pdfs\/journals\/1098-3015\/PIIS1098301511026325.pdf Last accessed 16th December 2013."},{"key":"369_CR39","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s11136-011-9938-z","volume":"21","author":"JW Kowalski","year":"2012","unstructured":"Kowalski JW, Rentz AM, Walt JG, Lloyd A, Lee J, Young TA, et al: Rasch analysis in the development of a simplified version of the National Eye Institute Visual-Function Questionnaire-25 for utility estimation. Qual Life Res. 2012, 21: 323-334.","journal-title":"Qual Life Res"},{"key":"369_CR40","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1001\/archopht.121.2.211","volume":"121","author":"TE Clemons","year":"2003","unstructured":"Clemons TE, Chew EY, Bressler SB, McBee W: National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 10. Arch Ophthalmol. 2003, 121: 211-217.","journal-title":"Arch Ophthalmol"},{"key":"369_CR41","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/archopht.119.7.1050","volume":"119","author":"CM Mangione","year":"2001","unstructured":"Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD: Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001, 119: 1050-1058.","journal-title":"Arch Ophthalmol"},{"key":"369_CR42","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1001\/archopht.119.5.733","volume":"119","author":"R Klein","year":"2001","unstructured":"Klein R, Moss SE, Klein BE, Gutierrez P, Mangione CM: The NEI-VFQ-25 in people with long-term type 1 diabetes mellitus: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Ophthalmol. 2001, 119: 733-740.","journal-title":"Arch Ophthalmol"},{"key":"369_CR43","first-page":"1017","volume":"41","author":"SR Cole","year":"2000","unstructured":"Cole SR, Beck RW, Moke PS, Gal RL, Long DT: The National Eye Institute Visual Function Questionnaire: experience of the ONTT. Optic neuritis treatment trial. Invest Ophthalmol Vis Sci. 2000, 41: 1017-1021.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"369_CR44","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1001\/archopht.121.4.531","volume":"121","author":"PH Miskala","year":"2003","unstructured":"Miskala PH, Hawkins BS, Mangione CM, Bass EB, Bressler NM, Dong LM, et al: Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization\u2013SST Report No. 1. Arch Ophthalmol. 2003, 121: 531-539.","journal-title":"Arch Ophthalmol"},{"key":"369_CR45","first-page":"919","volume":"94","author":"RK Parrish","year":"1996","unstructured":"Parrish RK: Visual impairment, visual functioning, and quality of life assessments in patients with glaucoma. Trans Am Ophthalmol Soc. 1996, 94: 919-1028.","journal-title":"Trans Am Ophthalmol Soc"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2415-13-74\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-13-74.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-13-74","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-13-74.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T22:47:42Z","timestamp":1716245262000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/1471-2415-13-74"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["369"],"URL":"https:\/\/doi.org\/10.1186\/1471-2415-13-74","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12]]},"article-number":"74"}}